Serán Bioscience
PrivateLast Round
Growth Equity
Sep 29, 2026
Total Funding Raised
$200M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Serán Bioscience operates in Healthcare & Life Sciences and is based in Bend, Oregon. Its latest recorded funding round was a Growth Equity round in September 2026.
Serán Bioscience is a contract development and manufacturing organization (CDMO) that provides a comprehensive suite of development, analytical, and clinical manufacturing services to pharmaceutical and biotechnology companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serán Bioscience Comparables
Compare Serán Bioscience with similar companies based on industry and business-model similarity.
No comparables are published for Serán Bioscience. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Serán Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 29, 2026 | ||||
| Private Equity | Sep 17, 2024 | ||||
| Debt | Jan 8, 2021 | ||||
| Private Equity | Jan 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Serán Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Growth Equity, Private Equity |
| Biospring Partners | Growth Equity |
| Monroe Capital | Private Equity, Debt |
| Vivo Capital | Private Equity, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2026
Biospring Partners led the round, joined by Vivo Capital and Bain Capital.
- Jul 27, 2026
Open roles increased to 407, 2.39x headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- increases_headcount_bySep 29, 2026
Serán Bioscience, LLC will hire as many as 150 additional employees as its commercial expansion progresses, creating a campus in Bend, Oregon.
For institutional investors. Book with your work email.
Serán Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Serán Bioscience's valuation, stock price, and market status.
Is Serán Bioscience a public or private company?
Serán Bioscience is a private company.
What is the current stock price of Serán Bioscience?
Serán Bioscience is a private company, so its shares have no public market price. Caplight tracks Serán Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Serán Bioscience worth (valuation)?
Valuation information for Serán Bioscience is not publicly available.
Can I buy Serán Bioscience stock?
Serán Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Serán Bioscience's last funding round?
Serán Bioscience's most recent funding round was Growth Equity on September 29, 2026.
Who are the main investors in Serán Bioscience?
Key investors in Serán Bioscience include Bain Capital Life Sciences, Biospring Partners, Monroe Capital, Vivo Capital.
Will Serán Bioscience IPO soon?
No public IPO plans have been announced for Serán Bioscience.
How can I track Serán Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Serán Bioscience's shares on secondary markets.